Nicox

Nicox is a biopharmaceutical company based in Warren, NJ, dedicated to developing innovative therapeutics aimed at maintaining vision and enhancing ocular health. The company focuses on a strong portfolio in the field of glaucoma and has established strategic partnerships to advance its product candidates.

Notably, Nicox's lead product candidate, NCX 470, is currently in clinical trials and represents a significant advancement in glaucoma treatment. The company continues to engage in key agreements and collaborations, reinforcing its commitment to addressing unmet medical needs in the eye care sector.

Generated from the website